The prices are being projected anywhere between $2.30 and $5! Just the short covering could easily drive the price into that price range!
Doesn't look like that the street is buying it, does it? The value is close to $2.50 in reality!
you've got to be a newbie, kido! see for yourself here:
The speculations are building up that Nokia has become a ripe takeover target and the bidding war on NOK will push the price up. Whether it's good for you depending on what you paid for your NOK shares. If you paid more than $20 a share, it's not likely that you'll recover your loss. you could lose the high dividends NOK now pays. However, everyone should be able to gain or recover some when the bidding war eventually starts :o).
the world's top chip maker within a year, become profitable in less than a year, and the client alert reiterated a strong aggressive buy under $10 and a long-term target of $30. Knowing SMI has the backing of the Chinese government, TSM has chosen to invest in SMI instead of head-on competition. More comments on the Chinese official report on its semiconductor industry to follow ...
If GSK bought HGSI, Novatis would be a single biggest loser. Bet all your money on it that Novatis will put up a real fight for HGSI unless Novatis gets enough compensation!
Sorry that your life in gambling got cut short so quickly, but you ignored all the sound analysis available to you so freely while digging your deep doodoo hole!!!
Oh yeah, how about BUY! BUY! BUY! until the 1-for-1 stock swamp deal with GSK is done?
Are HGSI shorts still clueless???
Be patient. One has to be a fool not to be able to see that HGSI will be bought out by GlaxoSmithCline sooner or later. $38 price tag is a piece of cake for GSK. It will be more likely to be a 1-to-1 deal, which should put the price tag around $40 a share.
raised to $33. Windows 7 is expected to boost Microsoft's earnings for the next quarter. Twitter teams up with Microsoft with MS' Bing search engine. More on the web.
It's inevitable that Gloxosmithcline will snatch Human Genome Sciences before HGSI gets way too expensive for GSK to buy!!! Berstein and a bunch of financial institutions are betting on it, so you would be abosolutely an idiot to give up your HGSI shares below $20!!!